These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 16632361)
1. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Nelson L; Owens H; Hynan LS; Iannaccone ST; Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361 [TBL] [Abstract][Full Text] [Related]
3. Spinal muscular atrophy: survival pattern and functional status. Chung BH; Wong VC; Ip P Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcome measures in spinal muscular atrophy. Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409 [TBL] [Abstract][Full Text] [Related]
5. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. O'Hagen JM; Glanzman AM; McDermott MP; Ryan PA; Flickinger J; Quigley J; Riley S; Sanborn E; Irvine C; Martens WB; Annis C; Tawil R; Oskoui M; Darras BT; Finkel RS; De Vivo DC Neuromuscul Disord; 2007 Oct; 17(9-10):693-7. PubMed ID: 17658255 [TBL] [Abstract][Full Text] [Related]
6. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C; Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348 [TBL] [Abstract][Full Text] [Related]
7. Impaired mandibular function in spinal muscular atrophy type II: need for early recognition. van Bruggen HW; van den Engel-Hoek L; van der Pol WL; de Wijer A; de Groot IJ; Steenks MH J Child Neurol; 2011 Nov; 26(11):1392-6. PubMed ID: 21596705 [TBL] [Abstract][Full Text] [Related]
9. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy. Febrer A; Rodriguez N; Alias L; Tizzano E J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217 [TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic study of spinal muscular atrophies in Oman. Koul R; Al Futaisi A; Chacko A; Rao V; Simsek M; Muralitharan S; Ganguly SS; Bayoumi R J Child Neurol; 2007 Oct; 22(10):1227-30. PubMed ID: 17940251 [TBL] [Abstract][Full Text] [Related]
11. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report. Dunaway S; Montes J; Ryan PA; Montgomery M; Sproule DM; De Vivo DC J Child Neurol; 2012 Jun; 27(6):779-85. PubMed ID: 22156787 [TBL] [Abstract][Full Text] [Related]
12. Features of motor control in patients with proximal childhood spinal muscle atrophy (pilot study). Bojakowski J; Dimitrijevic MR; Hausmanowa-Petrusewicz I; Sherwood AM; Wawro AW; Zalewska E Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):375-83. PubMed ID: 8223338 [TBL] [Abstract][Full Text] [Related]
13. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III. Kroksmark AK; Beckung E; Tulinius M Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107 [TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of outcome measures of in-hospital and at-home visits in a randomized, double-blind, placebo-controlled trial for spinal muscular atrophy. Chen TH; Yang YH; Mai HH; Liang WC; Wu YC; Wang HY; Jong YJ J Child Neurol; 2014 Dec; 29(12):1680-4. PubMed ID: 24163397 [TBL] [Abstract][Full Text] [Related]
16. New quantitative method for evaluation of motor functions applicable to spinal muscular atrophy. Matsumaru N; Hattori R; Ichinomiya T; Tsukamoto K; Kato Z Brain Dev; 2018 Mar; 40(3):172-180. PubMed ID: 29395660 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of motor performance and its relation to motor capacity in children with cerebral palsy. van Eck M; Dallmeijer AJ; Voorman JM; Becher JG Dev Med Child Neurol; 2009 Apr; 51(4):303-10. PubMed ID: 19335565 [TBL] [Abstract][Full Text] [Related]
19. Validation of the Gross Motor Function Measure for use in children and adolescents with traumatic brain injuries. Linder-Lucht M; Othmer V; Walther M; Vry J; Michaelis U; Stein S; Weissenmayer H; Korinthenberg R; Mall V; Pediatrics; 2007 Oct; 120(4):e880-6. PubMed ID: 17908744 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy. Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]